A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib in combination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia.Gilles Salles, Paolo Ghia, Nicole Lamanna et al.|Journal of Clinical Oncology|2014Cited by 10
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b studyDusan Kotasek, Timothy Price, Lillian L. Siu et al.|BMC Cancer|2011Cited by 9